Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q3 2025 Earnings Call Transcript

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q3 2025 Earnings Call Transcript November 4, 2025

Tarsus Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.35.

Operator: Good afternoon, and welcome to Tarsus’ Third Quarter 2025 Financial Results Conference Call. As a reminder this call is being recorded. [Operator Instructions] At this time, I would like to turn the call over to David Nakasone, Head of Investor Relations, to lead off the call. David,...